Idorsia Pharmaceuticals
Business Services · Pennsylvania, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1 Radnor Corporate Ctr Ste 100, Radnor, ...Website
www.idorsia.chRevenue
$100 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Idorsia Pharmaceuticals
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. After Actelion was bought by Johnson & Johnson in 2017, the Actelion founders, Jean-Paul and Martine Clozel, started their new business, located just across the road from the Actelion headquarters. The company expects to be profitable in 2025.Explore more
Idorsia Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Idorsia Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Idorsia Pharmaceuticals
Earning: See what the market has to say on Idorsia Pharmaceuticals recently announced quarterly report
Idorsia Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Idorsia Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Idorsia Pharmaceuticals has new funding data
Product Launch: Get notified when Idorsia Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Click to see if Idorsia Pharmaceuticals had a recent Job posting/layoffs
Check if Idorsia Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Idorsia Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Idorsia Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Idorsia Pharmaceuticals.
Idorsia Pharmaceuticals Tech Stack
A closer look at the technologies used by Idorsia Pharmaceuticals
Idorsia Pharmaceuticals News & Media
Idorsia Ltd (IDRSF) Discusses Positive Phase II Results for Daridorexant in Pediatric Insomnia and Neurodevelopmental Disorders Transcript
Idorsia Ltd (IDRSF) Discusses Positive Phase II Results for Daridorexant in Pediatric Insomnia and Neurodevelopmental Disorders March 31, 2026 9:00 AM...Idorsia Ltd Announces Chief Executive Officer Changes - MarketScreener
Idorsia Ltd. announced that Dr. Srishti Gupta and the Board of Idorsia have mutually agreed that Srishti will step down from her role as Chief Executive Officer . The Board has initiated the search...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Idorsia Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. After Actelion was bought by Johnson & Johnson in 2017, the Actelion founders, Jean-Paul and Martine Clozel, started their new business, located just across the road from the Actelion headquarters. The company expects to be profitable in 2025.... Read More
